Journal article
Timing of primary syphilis treatment and impact on the development of treponemal antibodies: A cross-sectional clinic-based study
JM Towns, DE Leslie, I Denham, F Azzato, T Karapanagiotidis, DA Williamson, SR Graves, CK Fairley, M Bissessor, EPF Chow, L Zhang, MY Chen
Sexually Transmitted Infections | BMJ PUBLISHING GROUP | Published : 2022
Abstract
Background Serology is negative in a proportion of primary syphilis cases where Treponema pallidum PCR testing is positive. We aimed to identify discordant, T. pallidum PCR-positive, serology-negative primary syphilis cases and any clinical or laboratory factors associated with failure to subsequently seroconvert. Methods Serodiscordant primary syphilis cases that were T. pallidum PCR-positive and serology-negative (including rapid plasma reagin, T. pallidum particle agglutination, T. pallidum enzyme immunoassay or T. pallidum chemiluminescence assay) were identified from the Melbourne Sexual Health Centre electronic records between April 2011 and December 2019. Clinical and laboratory assoc..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
JMT is supported by a Monash University Research Training Program Stipend and by a Royal Australasian College of Physicians Foundation Research Entry Scholarship. DW and EPFC are supported by an Australian NHMRC Emerging Leadership Investigator Grant (GNT1174555 and GNT1172873, respectively). CKF is supported by an Australian National Health and Medical Research Council (NHMRC) Leadership Investigator Grant (GNT1172900).